한글목차

세계 크리스퍼(CRISPR) 기술 시장의 미래는 제약 및 생명공학 기업, 학계 및 연구기관 시장에 기회가 있는 유망한 시장으로 평가받고 있습니다. 세계 CRISPR 기술 시장은 2025년부터 2031년까지 23.4%의 CAGR로 2031년까지 약 51억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 CRISPR 기술에 대한 정부의 투자 증가, 새로운 백신의 채택 및 유전성 질환 치료의 증가입니다.

• Lucintel의 예측에 따르면, 예측 기간 동안 제품 유형에서 제품이 더 큰 부문을 차지할 것으로 예상됩니다.
• 최종 용도별로는 제약 및 생명공학 기업이 계속해서 큰 비중을 차지할 것으로 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 큰 지역으로 남을 것으로 예상됩니다.

CRISPR 기술 시장의 전략적 성장 기회

CRISPR 기술 시장은 특히 이 다양한 기술의 전략적 적용을 모색하는 기업들에게 큰 성장 기회를 제공합니다. 따라서 이해관계자들은 혁신을 촉진하고 인간 건강, 농업 및 생명공학 분야의 시급한 문제를 해결하기 위한 확장 가능한 방법에 초점을 맞춰야 합니다.

• 유전자 치료제 개발 : 유전성 질환을 치료하기 위한 CRISPR 기반 유전자 치료제 개발에 투자함으로써 우수한 대체 치료법을 개발할 수 있습니다. 이 시장 부문은 표적 치료제에 대한 환자 수요 증가로 인해 성장할 것으로 예상됩니다.
• 농업 응용 분야에서의 혁신 : 농업, 특히 가뭄과 해충에 강한 작물 개발에서 CRISPR의 역할을 확대할 수 있는 잠재력이 매우 큽니다. 이러한 개입은 식량 불안과 싸우고 환경적으로 지속가능한 농법을 촉진하는 데 매우 중요합니다.
• 연구기관과의 협력 : 대학 및 연구기관과의 공동 프로젝트는 CRISPR 기술 활용 및 개발에 대한 새로운 아이디어를 창출할 가능성이 높습니다. 이러한 파트너십은 최신 과학 발전에 대한 접근성을 강화하고 지식 공유를 촉진할 수 있습니다.
• 윤리적 거버넌스의 중요성 : 대중의 동의를 얻기 위해서는 CRISPR과 같은 기술의 사용을 관리하는 전용 인프라를 구축하는 것이 필수적입니다. 윤리적 관행을 통합한 상장기업은 규제 및 홍보 문제에 직면할 가능성이 낮습니다.
• AI 기반 솔루션에 대한 투자 : 인공지능과 머신러닝 기술을 CRISPR 설계 및 실행에 적용함으로써 연구의 질을 향상시킬 수 있습니다. 이러한 투자는 유전자 편집의 정확성과 효율성을 향상시키고 시장 성장을 촉진할 것입니다.

이러한 전략적 성장 기회는 CRISPR 생태계의 혁신과 시장 확대에 대한 큰 잠재력을 보여줍니다. 이러한 기회를 활용함으로써 이해관계자들은 유전자 연구와 생명공학의 발전에 적극적으로 기여할 수 있을 것으로 보입니다.

CRISPR 기술 시장 활성화 요인 및 과제

CRISPR 기술 시장에도 기술 및 상업화, 규제 문제, 사회 수용성 등 많은 시장 촉진요인 및 과제가 있습니다. 시장 창출과 투자를 원하는 모든 사람과 관련된 요인이 있습니다. 이러한 요인들을 통해 시장 역학을 이해하는 것이 더 쉬워졌습니다.

CRISPR 기술 시장을 이끄는 요인은 다음과 같습니다:

• 기술의 변화 : 기존 CRISPR 기술에는 유전자 편집 과정의 정확성과 효율성을 향상시키는 몇 가지 혁신적인 기술이 계속 존재하고 있습니다. 이러한 변화는 헬스케어 및 농업 분야의 다양한 응용을 위한 CRISPR 기술에 대한 투자 의욕을 자극하고 있습니다.
• 바이오기술은 지금 더 많은 자금을 모으고 있습니다 : 민간 및 정부로부터의 자금지원이 증가하고 있으며, CRISPR 시장의 제품개발에 새로운 자금이 투입되고 있습니다. 자금 조달은 새로운 기술의 도입과 각각의 응용에 있어 중요한 기둥입니다.
• 환자 중심 의료의 증가 : 환자 맞춤형 의료로의 치료 접근 방식 전환으로 환자 치료를 위한 CRISPR 관련 의약품의 개발이 시급합니다. 이는 유전자 편집 기술의 한계에 부딪히며 유전자 치료 서비스 분야의 경쟁에 장벽이 될 수 있습니다.
• 유전질환에 대한 지식의 증가 : 유전질환과 그 결과에 대한 이해도가 높아지면서 더 높은 수준의 치료법을 찾는 환자들이 증가하고 있습니다. 이러한 이해는 다양한 치료법이 개발됨에 따라 CRISPR 시장 개척에 박차를 가하고 있습니다.
• 세계 연구 협력 : CRISPR의 다양한 분야에서의 발전은 전 세계 연구센터 간의 협력을 통해 비약적으로 향상되고 있습니다. 이러한 협력은 지식과 자원을 공유하고 획득할 수 있는 기회를 제공하여 혁신을 촉진합니다.

CRISPR 기술 시장의 과제는 다음과 같습니다:

• 윤리적 문제 : 유전자 편집에 CRISPR을 사용하는 것은 유전공학에 대한 우려, 장기적인 영향, "디자이너 베이비"의 탄생 등 심각한 윤리적 문제를 야기할 수 있습니다. 이러한 문제를 해결하는 것은 조직공학과 같은 분야의 미래 윤리적 관행에 매우 중요합니다.
• 지적재산권 문제 : CRISPR 시장은 여러 연구기관과 생명공학 기업 간의 특허 분쟁에 휘말려 있습니다. 지적재산권을 둘러싼 의견 대립은 협력을 방해하고, 창의성을 저해하며, 시장에 문제를 야기할 수 있습니다.
• 기술적 한계 : CRISPR 기술은 매우 효과적이지만, 여전히 표적 외 효과와 전달 방법의 한계라는 문제에 직면해 있습니다. 이러한 단점을 해소하는 것은 특히 치료에 적용하기 위해서는 필수적이지만, 더 많은 개선이 필요합니다.

이러한 문제들은 CRISPR 시장의 성장과 혁신 속도에 위험을 초래할 수 있습니다. 법적, 사회적, 절차적 장벽을 극복하는 것은 CRISPR 기술의 이점을 최소한의 관련 위험으로 실현하기 위해 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 CRISPR 기술 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2019년부터 2031년까지 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 CRISPR 기술 시장 동향(2019-2024) 및 예측(2025-2031)
• 유형별 : CRISPR 기술 세계 시장
  • 제품
  • 서비스
  • 기타
• 용도별 : CRISPR 기술 세계 시장
  • 의약품 발견과 개발
  • 농업
  • 기타
• 최종 용도별 : CRISPR 기술 세계 시장
  • 제약·바이오테크놀러지 기업
  • 학술조사기관
  • 기타

제4장 2019년부터 2031년까지 지역별 시장 동향과 예측 분석

• 지역별 : 세계의 CRISPR 기술 시장
• 북미의 CRISPR 기술 시장
• 유럽의 CRISPR 기술 시장
• 아시아태평양의 CRISPR 기술 시장
• 기타 지역의 CRISPR 기술 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별 : 세계의 CRISPR 기술 시장 성장 기회
  • 용도별 : 세계의 CRISPR 기술 시장 성장 기회
  • 최종 용도별 : 세계의 CRISPR 기술 시장 성장 기회
  • 지역별 : 세계의 CRISPR 기술 시장 성장 기회
• CRISPR 기술 세계 시장의 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 CRISPR 기술 시장 용량 확대
  • 세계의 CRISPR 기술 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Thermo Fisher Scientific
• Merck
• Agilent Technologies
• Genscript Biotech
• CRISPR Therapeutics
• Editas Medicine
• Intellia Therapeutics
• Beam Therapeutics
• Caribou Biosciences
• Lonza

영문목차

The future of the global clustered regularly interspaced short palindromic repeat technology market looks promising with opportunities in the pharmaceutical & biotechnology company and academic & research institute markets. The global clustered regularly interspaced short palindromic repeat technology market is expected to reach an estimated $5.1 billion by 2031 with a CAGR of 23.4% from 2025 to 2031. The major drivers for this market are the increasing investment from the government in CRISPR technology and the rising adoption of new vaccines and the treatment of genetic diseases.

• Lucintel forecasts that, within the type category, the product will remain the larger segment over the forecast period.
• Within the end use category, pharmaceutical & biotechnology companies will remain the larger segment.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

The clustered regularly interspaced short palindromic repeat technology market is presenting several emerging trends related to technological growth, regulatory changes, and increased usage of this technology across various sectors. These trends play a significant role in shaping the future of scientific inquiry, as well as the fields of molecular biology and biotechnology, particularly in antibiotic applications.

• Expansion of Therapeutic Applications: Scientists are increasingly working on the development of therapies for specific diseases, including CRISPR-based cancer immunotherapy. This is leading to clinical research progress through new investments that further the investigation, enabling better treatment results.
• Integration of AI and Machine Learning: The integration of AI and machine learning in CRISPR research is improving the accuracy of gene editing. These solutions allow scientists to forecast outcomes and enhance the effectiveness of editing techniques.
• Regulatory Harmonization: The gap in regulations is narrowing as countries establish rules for CRISPR and its applications. This is facilitating global engagement and accelerating the approval of CRISPR therapies.
• Focus on Sustainable Agriculture: CRISPR technologies are being used to develop crops that are more resistant to pests and diseases. This is crucial for food security and addressing the impacts of climate change.
• Ethical and Societal Discussions: There is increasing interest in discussing the ethical issues related to the advancement of CRISPR techniques. Public debates and legislative actions are evolving to mitigate risks associated with CRISPR technologies.

These new trends in biotechnology help prevent stagnation in the clustered regularly interspaced short palindromic repeat technology market by fostering new ideas, increasing efficiency, and ensuring responsible practices. As these trends evolve, stakeholders will need to manage them effectively to maximize the potential benefits of CRISPR technologies.

Recent Developments in the Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

Recent developments in the clustered regularly interspaced short palindromic repeat technology market are characterized by expanding budgets for research and the development of cutting-edge technologies, as well as the introduction of new practices in both new and existing industries. These trends reflect a paradigm shift taking place in genetic research and biotechnology, marking a significant upward movement.

• Advancements in CRISPR Delivery Methods: New CRISPR component delivery systems are being developed to improve targeting and reduce undesired effects from off-target areas. Researchers are making advancements such as using lipid nanoparticles and viral vectors, which enhance gene editing effectiveness and lead to safer therapies.
• Clinical Trials for Genetic Therapies: The initiation of clinical trials for CRISPR-based therapies, such as those targeting sickle cell anemia and muscular dystrophy, represents significant progress. These trials are providing crucial data that could transform treatment approaches and accelerate the development of CRISPR therapeutic solutions.
• Increased Funding from Governments and Private Sectors: Both government agencies and private investors are making substantial investments in CRISPR research. This funding is driving the development of new technologies and applications, supporting creativity and innovation.
• Emergence of CRISPR in Agriculture: CRISPR is becoming more widely used in agriculture to develop stress-resistant modified plants. This advancement is key to improving food security and addressing the challenges posed by climate change.
• Global Collaborations in CRISPR Research: Researchers are increasingly engaging in international collaborations to tap into additional resources and improve their research efforts. These collaborations are helping push the boundaries of CRISPR technology development and the growth of research programs.

These recent developments are positively influencing the clustered regularly interspaced short palindromic repeat technology market, leading to better innovations and the expanded use of the technology. Moving forward, as the market continues to grow, ongoing research and collaboration will be essential to realizing the full potential of CRISPR technologies.

Strategic Growth Opportunities for Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

The clustered regularly interspaced short palindromic repeat technology market offers significant opportunities for growth, particularly for those seeking to explore strategic applications of this diverse technology. In light of this, stakeholders should focus on scalable methods to foster innovation and address pressing issues in human health, agriculture, and biotechnology.

• Development of Gene Therapies: Investing in the development of CRISPR-based gene therapies for treating genetic disorders can yield excellent treatment alternatives. This market segment is poised for growth, driven by increasing patient demand for targeted therapeutics.
• Innovations in Agricultural Applications: There is considerable potential to expand CRISPR's role in agriculture, particularly in developing drought- and pest-resistant crops. This intervention is crucial for combating food insecurity and promoting environmentally sustainable farming practices.
• Collaboration with Research Institutions: Joint projects with universities and research-focused organizations are likely to generate new ideas for the use and development of CRISPR technologies. These partnerships can enhance access to the latest scientific advancements and facilitate knowledge sharing.
• Focus on Ethical Governance: To ensure public buy-in, it is essential to establish infrastructure dedicated to governing the use of technologies like CRISPR. Companies that integrate ethical practices are likely to face fewer regulatory and public relations challenges.
• Investment in AI-Driven Solutions: The application of artificial intelligence and machine learning technologies to CRISPR design and implementation will enhance research quality. This investment will improve the accuracy and efficiency of gene editing, thus driving market growth.

These strategic growth opportunities highlight the substantial potential for innovation and market expansion within the CRISPR ecosystem. By capitalizing on these opportunities, stakeholders will contribute positively to the advancement of genetic research and biotechnology.

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market Driver and Challenges

The clustered regularly interspaced short palindromic repeat technology market too has a number of drivers and challenges among them being, technology and its commercialization, regulatory issues, and acceptance from society. There are factors that are relevant to all who wish to create or invest in the market. These factors have made it easier to understand the market dynamics.

The factors responsible for driving the clustered regularly interspaced short palindromic repeat technology market include:

• Changes in Technology: There continue to be several ongoing innovations related to existing CRISPR technologies that are improving the level of precision and efficiency of the gene editing process. These changes are triggering the appetite and investments in CRISPR technologies for various applications in healthcare and agriculture.
• Bio-Tech Now Attracts More Funding: Private and government funding is on the rise bringing new money into the development of products in the CRISPR market. Funding is an important pillar in the introduction of new technologies and their respective applications.
• Increase In Patient Rooted Medicine: The transformation of the treatment approach toward patient-specific medicine makes it exigent to develop CRISPR-related medicines for patients' treatment. This forces the limits of gene editing technology and adds barriers to competition in the area of genetic treatment services.
• Increase In The Knowledge Concerning Genetic Disorders: A rise in the comprehension of genetic disorders and their outcomes is leading more patients to look for higher levels of remedies. Such understanding is fueling the development of the CRISPR market as different possibilities for therapies are being developed.
• Global Collaboration in Research: Progress in the different domains of CRISPR is improving in leaps and bounds because of collaboration among global research centers. These collaborations provide opportunities for sharing and acquiring knowledge and resources thereby boosting innovation.

Challenges in the clustered regularly interspaced short palindromic repeat technology market are:

• Ethical Concerns: The use of CRISPR in gene editing raises significant ethical issues, including concerns about genetic engineering, its long-term consequences, and the creation of "designer babies." Addressing these concerns will be crucial for future ethical practices in fields like tissue engineering.
• Intellectual Property Issues: The CRISPR market is entangled in competing patent disputes between multiple institutions and biotech companies. Disagreements over intellectual property rights can hinder cooperation and stifle creativity, creating challenges for the market.
• Technical Limitations: While CRISPR technology is highly effective, it still faces challenges such as off-target effects and limitations in delivery methods. Eliminating these drawbacks is essential, particularly for therapeutic applications, though further improvements are needed.

These challenges pose risks to the CRISPR market's growth and the rate of innovation. Overcoming legal, social, and procedural barriers will be essential for realizing the benefits of CRISPR technology with minimal associated risks.

List of Clustered Regularly Interspaced Short Palindromic Repeat Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies clustered regularly interspaced short palindromic repeat technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clustered regularly interspaced short palindromic repeat technology companies profiled in this report include-

• Thermo Fisher Scientific
• Merck
• Agilent Technologies
• Genscript Biotech
• CRISPR Therapeutics
• Editas Medicine
• Intellia Therapeutics
• Beam Therapeutics
• Caribou Biosciences
• Lonza

Clustered Regularly Interspaced Short Palindromic Repeat Technology by Segment

The study includes a forecast for the global clustered regularly interspaced short palindromic repeat technology market by type, application, end use, and region.

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Type [Analysis by Value from 2019 to 2031]:

• Product
• Service
• Others

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Application [Analysis by Value from 2019 to 2031]:

• Drug Discovery & Development
• Agriculture
• Others

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by End Use [Analysis by Value from 2019 to 2031]:

• Pharmaceutical & Biotechnology Company
• Academic & Research Institute
• Others

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

The clustered regularly interspaced short palindromic repeat (CRISPR) market has undergone rapid changes in recent years, particularly in major global markets such as the USA, China, Germany, India, and Japan. These countries are experiencing new trends, such as increased research funding, regulatory changes, and the adoption of new therapies, which are creating opportunities in this ever-evolving industry.

• United States: In the United States, CRISPR research is advancing significantly, with new developments, including approved CRISPR therapies for clinical use in treating inherited genetic disorders. Companies like Referral Therapeutics are partnering with Aristech Corporations and Miyuki Biopharma to advance gene therapies. Additionally, collaborations between universities and the pharmaceutical industry are becoming more active, driving progress in CRISPR techniques and strategies.
• China: China has positioned itself as a global leader in CRISPR research, actively seeking funding and developing gene engineering technologies. The country is also funding agricultural CRISPR innovations aimed at improving crop quality and production. Chinese biotech firms are conducting clinical trials for CRISPR-based therapies targeting various cancers and genetic disorders, while regulatory policies are becoming more flexible and conducive to CRISPR development.
• Germany: Germany is one of the European countries leading CRISPR research, with several research institutions focusing on gene editing applications. There has been a notable increase in investment in CRISPR projects, particularly in major export crops and health care reforms. Efforts are underway to develop more accurate and efficient CRISPR delivery systems. Additionally, Germany is engaging the public in discussions about the ethics of CRISPR technology, ensuring that ethics and science progress together.
• India: India is making significant strides in the CRISPR market, focusing on agricultural advancements and cost-effective healthcare solutions. Recent developments include partnerships between startups and research institutions to improve crop resilience. Regulators are beginning to establish frameworks for gene editing technologies, which is vital for promoting development. Educational programs are also being introduced to raise awareness of the positive aspects of CRISPR technologies and their potential impacts.
• Japan: Healthcare and therapeutic applications dominate Japan's CRISPR market, with recent progress in developing CRISPR-based therapies for rare genetic diseases. Japanese researchers are collaborating internationally to accelerate CRISPR technology advancements. The government is also funding proposals focused on precision medicine, strengthening the country's position in genomics and biotechnology.

Features of the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

Market Size Estimates: Clustered regularly interspaced short palindromic repeat technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecasts (2025 to 2031) by various segments and regions.

Segmentation Analysis: Clustered regularly interspaced short palindromic repeat technology market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Clustered regularly interspaced short palindromic repeat technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the clustered regularly interspaced short palindromic repeat technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clustered regularly interspaced short palindromic repeat technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the clustered regularly interspaced short palindromic repeat technology market by type (product, service, and others), application (drug discovery & development, agriculture, and others), end use (pharmaceutical & biotechnology company, academic & research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Type
  • 3.3.1: Product
  • 3.3.2: Service
  • 3.3.3: Others
• 3.4: Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Application
  • 3.4.1: Drug Discovery & Development
  • 3.4.2: Agriculture
  • 3.4.3: Others
• 3.5: Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by End Use
  • 3.5.1: Pharmaceutical & Biotechnology Company
  • 3.5.2: Academic & Research Institute
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Region
• 4.2: North American Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 4.2.1: North American Market by Type: Product, Service, and Others
  • 4.2.2: North American Market by End Use: Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Others
• 4.3: European Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 4.3.1: European Market by Type: Product, Service, and Others
  • 4.3.2: European Market by End Use: Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Others
• 4.4: APAC Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 4.4.1: APAC Market by Type: Product, Service, and Others
  • 4.4.2: APAC Market by End Use: Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Others
• 4.5: ROW Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 4.5.1: ROW Market by Type: Product, Service, and Others
  • 4.5.2: ROW Market by End Use: Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Type
  • 6.1.2: Growth Opportunities for the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Application
  • 6.1.3: Growth Opportunities for the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by End Use
  • 6.1.4: Growth Opportunities for the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Region
• 6.2: Emerging Trends in the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Merck
• 7.3: Agilent Technologies
• 7.4: Genscript Biotech
• 7.5: CRISPR Therapeutics
• 7.6: Editas Medicine
• 7.7: Intellia Therapeutics
• 7.8: Beam Therapeutics
• 7.9: Caribou Biosciences
• 7.10: Lonza